menu
    • menu

    Company profile for Theseus Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Theseus Pharmaceuticals is passionately committed to outsmarting cancer resistance. Cancer is constantly mutating, allowing it to evade initially effective oncology treatments. Theseus believes we can predict how cancer will change, enabling new therapies to stay ahead of future mutations and overcome the challenge of treatment resistance. Led by a team of pioneers in the discovery and development of tyrosine kinase inhibitors...
    Theseus Pharmaceuticals is passionately committed to outsmarting cancer resistance. Cancer is constantly mutating, allowing it to evade initially effective oncology treatments. Theseus believes we can predict how cancer will change, enabling new therapies to stay ahead of future mutations and overcome the challenge of treatment resistance. Led by a team of pioneers in the discovery and development of tyrosine kinase inhibitors (TKIs), we are developing best-in-class, pan-variant kinase inhibitors, to shape the future of targeted oncology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Theseus PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    210 Broadway Street Cambridge, MA 02139
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://theseusrx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/theseus-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ex-Theseus execs extend GIST mission by taking helm of IDRx
    Ex-Theseus execs extend GIST mission by taking helm of IDRx

    12 Mar 2024

    // Kyle LaHucik ENDPTS

    https://endpts.com/ex-theseus-execs-extend-gist-mission-by-taking-helm-of-idrx/

    Kyle LaHucik ENDPTS
    12 Mar 2024
    Share Share
    Theseus Pharmaceuticals Announces Closing of Tender Offer
    Theseus Pharmaceuticals Announces Closing of Tender Offer

    14 Feb 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/theseus-pharmaceuticals-announces-closing-of-tender-offer-302061474.html

    PR NEWSWIRE
    14 Feb 2024
    Share Share
    Concentra scores another win as Theseus agrees to buyout offer
    Concentra scores another win as Theseus agrees to buyout offer

    21 Dec 2023

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/concentra-scores-another-win-theseus-agrees-buyout-offer

    James Waldron FIERCE BIOTECH
    21 Dec 2023
    Share Share
    Theseus Confirms Receipt of Expression of Interest from Foresite Capital
    Theseus Confirms Receipt of Expression of Interest from Foresite Capital

    27 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/theseus-pharmaceuticals-confirms-receipt-of-unsolicited-expression-of-interest-from-foresite-capital-llc-and-orbimed-advisors-llc-and-unsolicited-proposal-from-concentra-biosciences-llc-301997491.html

    PR NEWSWIRE
    27 Nov 2023
    Share Share
    Months after ending cancer program, Theseus lays off 72%
    Months after ending cancer program, Theseus lays off 72%

    15 Nov 2023

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/months-after-ending-cancer-program-theseus-lays-72-staff-it-considers-options

    James Waldron FIERCE BIOTECH
    15 Nov 2023
    Share Share
    Theseus Pharmaceuticals Announces Process to Explore Strategic Alternatives
    Theseus Pharmaceuticals Announces Process to Explore Strategic Alternatives

    13 Nov 2023

    // PRESS RELEASE

    https://ir.theseusrx.com/2023-11-13-Theseus-Pharmaceuticals-Announces-Process-to-Explore-Strategic-Alternatives

    PRESS RELEASE
    13 Nov 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search